Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Frontiers in Behavioral Neuroscience|November 1, 2021
Melatonin Blocks Morphine-Induced Place Preference: Involvement of GLT-1, NF-κB, BDNF, and CREB in the Nucleus AccumbensBadrah S Alghamdi, Fahad S AlshehriFrontiers in Pharmacology|February 21, 2025
Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trialsAlqassem Y Hakami, Fahad S AlshehriJournal of Multidisciplinary Healthcare|August 7, 2023
Usage of Glucagon-Like Peptide-1 for Obesity in Children; Updated Review of Clinicaltrials.govNasser M Alorfi, Fahad S AlshehriFrontiers in Pharmacology|February 24, 2023
Protective role of resveratrol against VCM-induced hepatotoxicity in male wistar ratsFahad S Alshehri, Nasser M AlorfiJournal of Molecular Neuroscience : MN|November 27, 2016
Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and HippocampusFahad S Alshehri, Yusuf S Althobaiti, Youssef SariFrontiers in Public Health|March 27, 2023
Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov databaseNasser M Alorfi, Fahad S Alshehri, Abdul HaseebBehavioural Brain Research|September 27, 2018
β-lactams modulate astroglial glutamate transporters and attenuate dependence to CP 55,940, a CB1 receptor agonist, in rat modelAlqassem Y Hakami, Fahad S Alshehri, Youssef SariThrombosis Research|October 18, 2025
The fibrinolytic system in disease: From molecular pathways to clinical outcomesMohamed Nazem Alibrahim, Khaled A Sahli, Fahad S AlshehriRisk Management and Healthcare Policy|April 3, 2025
Public Awareness and Perceptions of Congenital Disabilities in Saudi Arabia: A Cross-Sectional StudyFahad S Alshehri, Ahmed M Ashour, Nasser M AlorfiDrug Design, Development and Therapy|April 1, 2025
Therapeutics for Sarcopenia and Functional Disabilities in Older Adults: A Review of Phase 4 Clinical TrialsNasser M Alorfi, Fahad S Alshehri, Ahmed M AshourPageof 8